LobbyingST. Baldrick's Foundation lobbying by quarter
ST. Baldrick's Foundation's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
ST. Baldrick's Foundation
- Latest quarter
- $0
- Q2 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $37.5K | 1 |
| Q1 2023 | $71.9K | 2 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
Policy issues the reports name
- Health issues13 reports
- Medical research and clinical labs12 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES16 reports
- SENATE16 reports
- Food & Drug Administration (FDA)14 reports
- Natl Institutes of Health (NIH)14 reports
- Office of Science & Technology Policy (OSTP)14 reports
Firms it paid
| Firm | ||
|---|---|---|
| Mathis Strategies | $69.4K | 2 quarters |
| In-houseST. Baldrick's Foundation | $50K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/11for Q2 | In-house | Under $5,000 |
| 07/17for Q2 | In-house | Under $5,000 |
| 05/04for Q1 | In-house | Under $5,000 |
| 02/10for Q4 2025 | In-house | Under $5,000 |
| 01/21for Q4 2025 | In-house | Under $5,000 |
| 25/11/06for Q3 2025 | In-house | Under $5,000 |
| 25/08/05for Q2 2025 | In-house | Under $5,000 |
| 25/05/05for Q1 2025 | In-house | Under $5,000 |
| 25/02/04for Q4 2024 | In-house | Under $5,000 |
| 24/11/20for Q3 2024 | In-house | Under $5,000 |
| 24/08/22for Q2 2024 | In-house | Under $5,000 |
| 24/05/07for Q1 2024 | In-house | Under $5,000 |
| 24/02/21for Q4 2023 | In-house | Under $5,000 |
| 24/02/15for Q4 2023 | In-house | Under $5,000 |
| 24/02/15for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | Under $5,000 |
| 23/07/18for Q2 2023 | In-house | $10K |
| 23/04/17for Q1 2023 | In-house | $40K |
| 23/03/17for Q1 2023 | Mathis Strategies | $31.9K |
| 23/02/10for Q1 2023 | In-house | Under $5,000 |